Vascular Endothelial Growth Factor Inhibitor class drugs
1 result
Byooviz (ranibizumab-nuna)
(ranibizumab-nuna)BIOGEN INC.
Usage: BYOOVIZ is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV).